Skip to main content
. 2023 Aug 7;10(10):1738–1748. doi: 10.1002/acn3.51863

Table 2.

Changes in AD drug prescribing pre‐ and post‐PrecivityAD blood testing.

APS category AD drug use p‐value Relative change from usual care
Pre Post
Low (n = 133) 64 (48%) 34 (26%) <0.0001 46% decrease
Intermediate (n = 52) 26 (50%) 21 (40%) 0.431 20% decrease
High (n = 162) 91 (56%) 142 (88%) <0.0001 57% increase
Overall 181 (52%) 197 (57%) 0.253 10% increase